Dyne Therapeutics Inc Earnings

The next earnings date for Dyne Therapeutics Inc is October 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Dyne Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
10/30/2025$-0.84

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Dyne Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
07/31/2025---$-0.97-2.99%
05/22/2025Before Market$-1.05-25.54%
03/03/2025Before Market$-0.883.51%
11/04/2024Before Market$-0.96-35.61%
08/01/2024Before Market$-0.702.78%
05/02/2024After Market$-0.81-1.25%
03/05/2024Before Market$-1.09-18.48%
10/30/2023Before Market$-0.99-19.28%
08/03/2023Before Market$-1.08-33.33%
05/11/2023Before Market$-0.78-1.30%
03/02/2023Before Market$-0.7411.90%
11/03/2022Before Market$-0.8013.04%
08/04/2022Before Market$-1.01-31.17%
05/02/2022After Market$-0.6921.59%
03/10/2022Before Market$-1-1.01%
11/04/2021Before Market$-0.83-29.69%
08/05/2021Before Market$-0.58-5.45%
05/06/2021Before Market$-0.5016.67%
03/04/2021Before Market$-0.64-72.97%
11/05/2020Before Market$-2.01-131.03%
09/17/2020After Market$-0.39---
12/31/2017---$-0.3516.67%
09/30/2017---$0.31-43.64%
06/30/2017---$-1.12-57.75%
03/31/2017---$-1.24-1,027.27%
12/31/2016---$-1.40-1,100.00%
09/30/2016---$-0.30-242.86%
06/30/2016---$-1.36-97.10%

More About Dyne Therapeutics Inc

Country
USA
Full Time Employees
206

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Dyne Therapeutics Inc Earnings” Can Refer to the Dyne Therapeutics Inc Earnings Date

Some people say “Dyne Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Dyne Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Dyne Therapeutics Inc Stock on the Earnings Date

If you own Dyne Therapeutics Inc stock (DYN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Dyne Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Dyne Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Dyne Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Dyne Therapeutics Inc earnings or anything else related to the stock market.